Cargando…
Tumor-specific CD4(+) T cells eradicate myeloma cells genetically deficient in MHC class II display
CD4(+) T cells have been shown to reject tumor cells with no detectable expression of major histocompatibility complex class II (MHC II). However, under certain circumstances, induction of ectopic MHC II expression on tumor cells has been reported. To confirm that CD4(+) T cell-mediated anti-tumor i...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341866/ https://www.ncbi.nlm.nih.gov/pubmed/27626487 http://dx.doi.org/10.18632/oncotarget.11946 |